全文获取类型
收费全文 | 487篇 |
免费 | 26篇 |
专业分类
儿科学 | 14篇 |
妇产科学 | 13篇 |
基础医学 | 53篇 |
口腔科学 | 7篇 |
临床医学 | 85篇 |
内科学 | 90篇 |
皮肤病学 | 18篇 |
神经病学 | 101篇 |
特种医学 | 10篇 |
外科学 | 26篇 |
预防医学 | 35篇 |
眼科学 | 3篇 |
药学 | 31篇 |
肿瘤学 | 27篇 |
出版年
2023年 | 9篇 |
2022年 | 3篇 |
2021年 | 10篇 |
2020年 | 12篇 |
2019年 | 19篇 |
2018年 | 13篇 |
2017年 | 9篇 |
2016年 | 12篇 |
2015年 | 11篇 |
2014年 | 19篇 |
2013年 | 32篇 |
2012年 | 31篇 |
2011年 | 34篇 |
2010年 | 23篇 |
2009年 | 19篇 |
2008年 | 29篇 |
2007年 | 30篇 |
2006年 | 26篇 |
2005年 | 24篇 |
2004年 | 23篇 |
2003年 | 12篇 |
2002年 | 22篇 |
2001年 | 12篇 |
2000年 | 17篇 |
1999年 | 5篇 |
1998年 | 3篇 |
1997年 | 6篇 |
1996年 | 5篇 |
1994年 | 2篇 |
1992年 | 4篇 |
1991年 | 2篇 |
1989年 | 2篇 |
1988年 | 3篇 |
1987年 | 1篇 |
1986年 | 3篇 |
1985年 | 2篇 |
1984年 | 2篇 |
1982年 | 1篇 |
1980年 | 1篇 |
1978年 | 4篇 |
1977年 | 1篇 |
1976年 | 1篇 |
1975年 | 1篇 |
1973年 | 2篇 |
1971年 | 1篇 |
1969年 | 1篇 |
1967年 | 2篇 |
1966年 | 3篇 |
1963年 | 1篇 |
1938年 | 1篇 |
排序方式: 共有513条查询结果,搜索用时 0 毫秒
511.
512.
Supra-physiological doses of anabolic androgenic steroids impact erythropoietin and blood parameters
Carmel E. Heiland Yasmin Schickel Mikael Lehtihet Annica Börjesson Lena Ekström 《Drug testing and analysis》2023,15(6):599-604
Hematological parameters and erythropoiesis are known to be influenced by anabolic androgenic steroid (AAS) use. However, little is known in relation to supra-physiological doses of AAS. Therefore, the aim of this study was to evaluate the effect of supra-physiological doses of AAS on serum and urinary erythropoietin (EPO), and blood parameters, from self-reported AAS users. Serum EPO levels were higher in testosterone positive AAS users (11.83 mIU/mL ± 4.19) than nonpositive (6.60 mIU/mL ± 2.70, p = 0.03), while no differences in urinary EPO levels were noted. There were positive correlations between serum EPO and testosterone levels (rs = 0.46, p = 0.01) and reticulocyte percentage (rs = 0.43, p = 0.02). Individuals with AAS-induced hypogonadism (ASIH; luteinizing hormone levels <1.4 IU/L) had approximately 75% higher serum EPO (p < 0.05) and 140% higher high fluorescence reticulocyte fractions (p < 0.001), as well as other affected hematological parameters, compared with non-ASIH individuals. The results extend the knowledge of how endocrine and hematological biomarkers are affected by AAS doping. 相似文献
513.
Bahare Makvandi Anton Pohanka Mats Bergström Annica Börjesson Mikael Lehtihet Lena Ekström Yufang Zheng 《Drug testing and analysis》2023,15(6):678-688
When testing for anabolic androgenic steroids (AAS) outside sports communities, for example, in healthcare and forensic medicine, urine is the matrix of choice. However, there are drawbacks with urinary sampling, and serum might be useful as a complementary matrix. The aim was to develop an LC–MS/MS method for serum measuring AAS frequently used outside of sport, including testosterone (T), steroid esters, and eight other synthetic AAS. The sample pretreatment included sample precipitation and evaporation. Limit of quantification for the AAS was 0.05–0.5 ng/mL, and linearity was 0.05–20 ng/mL for most of the substances. Generally, the within- and between-day CV results, matrix effect, and process efficiency were <15%. The AAS were stable for at least 6 months at −20°C. Serum samples were obtained from previous studies. A novel finding from an administration study was that T enanthate was present in serum even after 5 years of storage at −20°C. Serum samples from self-reporting AAS individuals, where T esters were detected, were positive for testosterone using the urinary testosterone/epitestosterone criterion >10. Of those identified as positive in traditional urinary doping tests (n = 15), AAS in serum were found in 80% of the subjects. Our results show that serum may be a valid complementary matrix to urine samples for AAS testing. 相似文献